Midas Management’s Quest Diagnostics DGX Stock Holding History

Midas Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,000	Closed	-$2.37M	–	160
2016 Q3	$2.37M	Hold	28,000	–	–	1.45%	11
2016 Q2	$2.28M	Hold	28,000	–	–	1.29%	13
2016 Q1	$2M	Hold	28,000	–	–	1.04%	18
2015 Q4	$1.99M	Hold	28,000	–	–	1.18%	19
2015 Q3	$1.72M	Hold	28,000	–	–	1.11%	29
2015 Q2	$2.03M	Hold	28,000	–	–	1.09%	27
2015 Q1	$2.15M	Hold	28,000	–	–	1.07%	25
2014 Q4	$1.88M	Hold	28,000	–	–	0.98%	35
2014 Q3	$1.7M	Hold	28,000	–	–	0.94%	42
2014 Q2	$1.64M	Hold	28,000	–	–	1.06%	38
2014 Q1	$1.62M	Buy	+28,000	New	+$1.5M	0.75%	57

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Midas Management's DGX Position: Q4 2016 in Review

Midas Management sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 28,000 shares — an estimated $2.37M sold.

Midas Management first reported a position in DGX in Q1 2014 and held it in 11 quarters. The position peaked at $2.37M in Q3 2016. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

Midas Management reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
Midas Management sold 28,000 Quest Diagnostics shares in Q4 2016, an estimated $2.37M.
Midas Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 11 quarters.
Midas Management's Quest Diagnostics position peaked at $2.37M in Q3 2016.
597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Midas Management's 13F filing for Q4 2016, filed 7 Feb 2017.